1.0Inovestorhttps://www.inovestor.com/en-ca/Inovestorhttps://www.inovestor.com/en-ca/author/inovestor/rich600338<blockquote class="wp-embedded-content" data-secret="stVXbZi175"><a href="https://www.inovestor.com/en-ca/2015/08/gilead-sciences-gild/">Gilead Sciences (GILD)</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.inovestor.com/en-ca/2015/08/gilead-sciences-gild/embed/#?secret=stVXbZi175" width="600" height="338" title="“Gilead Sciences (GILD)” — Inovestor" data-secret="stVXbZi175" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.inovestor.com/wp-includes/js/wp-embed.min.js </script> This week we take a look at Gilead Sciences (GILD), arguably one of the strongest stocks in the biotech industry today from an EVA perspective. Gilead is specialized in the development and commercialization of human therapeutics for the treatment of life threatening diseases, and currently controls the market for HCV (Hepatitis-C).  According to Street Insider […]